| Synonyms: | |
| Status: | Phase 1 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 28RYY2IV3F |
Structure
| InChI Key | SHZGCJCMOBCMKK-DHVFOXMCSA-N |
|---|---|
| Smile | |
| InChI |
|
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C6H12O5 |
| Molecular Weight | 164.16 |
| AlogP | -2.19 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 4.0 |
| Number of Rotational Bond | 0.0 |
| Polar Surface Area | 90.15 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 11.0 |
Pharmacology
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Protease
Serine protease
Serine protease PA clan
Serine protease S1A subfamily
|
- | - | - | - | 20 | |
|
Unclassified protein
|
- | 910-2740 | - | - | - |
Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Tissue Adhesions | Phase 1/Phase 2 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEBI | 2181 |
| ChEMBL | CHEMBL469449 |
| FDA SRS | 28RYY2IV3F |
| Guide to Pharmacology | 4721 |
| KEGG | C01019 |
| SureChEMBL | SCHEMBL63943 |
CONTENTS